Sign in
4

Changes in Ownership

ImmunityBio, Inc. Filed Acc 0001326110-26-000084

Director sold 81,056 shares at $10.50 ($851,088)

  • Director acquired 55,979 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Cohen Cheryl · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-02 Exercise or conversion : show line 1 in the form 10b5-1 +55,979 $2.98 $166,817 181,365 D
2026-10-02 Sale : show line 2 in the form 10b5-1 −81,056 $10.50 $851,088 100,309 D
Open-market sales · 81,056 sh · avg $10.50 · $851,088

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-02 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −55,979 55,979 D
Loading xslF345X06/wk-form4_1791324339.xml…